Demeter, L. M., Shafer, R. W., Meehan, P. M., Holden-Wiltse, J., Fischl, M. A., Freimuth, W. W., . . . Reichman, R. C. (2000). Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates from Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260). Antimicrob Agents Chemother.

Demeter, L. M., R. W. Shafer, P. M. Meehan, J. Holden-Wiltse, M. A. Fischl, W. W. Freimuth, M. F. Para, and R. C. Reichman. "Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates From Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260)." Antimicrob Agents Chemother 2000.

Demeter, L. M., et al. "Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates From Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260)." Antimicrob Agents Chemother 2000.